Electromed Q1 FY2022 revenue hits record $10.0M, up 25% YoY; EPS $0.05 vs $0.06

Electromed, Inc.

2022-Q1 EPS reported $0.05 revenue$10,001,000

Net revenue $10.0M, record quarterly; home care up 24.4% to $9.3M, institutional up 61.5% to $449K.
Net income $439K ($0.05 diluted EPS) vs $535K ($0.06) prior year; operating income $538K vs $663K.
Gross margin 77.0% vs 76.8%; SG&A rose to 67.9% of revenue due to strategic investments and shareholder activism costs.
Cash $11.0M, no debt; field sales employees 51 (41 direct reps), with record annualized home care revenue per rep of $955K.
Next-gen airway clearance device expected to launch in first half of FY2023 after FDA 510(k) clearance.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.